Panel Discussion: Delving into Novel Design & Development to Strive for Next-Generation ADCs Providing Long-Term Benefit to Patients

By | 4 June 2025

Moderator:

Jeffrey Settleman

Senior Vice President, Chief Scientific Officer, Oncology R&D, Pfizer